These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2914022)

  • 1. Species differences in the effects of bezafibrate, a hypolipidemic agent, on hepatic peroxisome-associated enzymes.
    Watanabe T; Horie S; Yamada J; Isaji M; Nishigaki T; Naito J; Suga T
    Biochem Pharmacol; 1989 Jan; 38(2):367-71. PubMed ID: 2914022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of selected hypolipidemic agents for the induction of peroxisomal enzymes and peroxisome proliferation in the rat liver.
    Lalwani ND; Reddy MK; Qureshi SA; Sirtori CR; Abiko Y; Reddy JK
    Hum Toxicol; 1983 Jan; 2(1):27-48. PubMed ID: 6840792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective induction of peroxisomal enzymes by the hypolipidemic drug bezafibrate. Detection of modulations by automatic image analysis in conjunction with immunoelectron microscopy and immunoblotting.
    Beier K; Völkl A; Hashimoto T; Fahimi HD
    Eur J Cell Biol; 1988 Aug; 46(3):383-93. PubMed ID: 2903052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of some anti-inflammatory drugs on biochemical values and on hepatic peroxisomal enzymes of rat.
    Watanabe T; Suga T
    J Pharmacobiodyn; 1985 Dec; 8(12):1060-7. PubMed ID: 3834060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the response of Sprague-Dawley and Lewis rats to bezafibrate: the hypolipidemic effect and the induction of peroxisomal enzymes.
    Pill J; Völkl A; Hartig F; Fahimi HD
    Arch Toxicol; 1992; 66(5):327-33. PubMed ID: 1610295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity in the action of hypolipidemic drugs: increase of peroxisomal beta-oxidation largely dissociated from hepatomegaly and peroxisome proliferation in the rat.
    Lazarow PB; Shio H; Leroy-Houyet MA
    J Lipid Res; 1982 Feb; 23(2):317-26. PubMed ID: 7077146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic peroxisomal changes induced by a tetrazole-substituted alkoxyacetophenone in rats and comparison with other species.
    Eacho PI; Foxworthy PS; Johnson WD; Hoover DM; White SL
    Toxicol Appl Pharmacol; 1986 May; 83(3):430-7. PubMed ID: 3754661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of calmodulin- and protein kinase C-related mechanism in an induction process of peroxisomal fatty acid oxidation-related enzymes by hypolipidemic peroxisome proliferators.
    Watanabe T; Okawa S; Itoga H; Imanaka T; Suga T
    Biochim Biophys Acta; 1992 Apr; 1135(1):84-90. PubMed ID: 1591274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of hepatic peroxisome proliferation in nonrodent species, including primates.
    Reddy JK; Lalwani ND; Qureshi SA; Reddy MK; Moehle CM
    Am J Pathol; 1984 Jan; 114(1):171-83. PubMed ID: 6691413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the inducing effect of dehydroepiandrosterone on hepatic peroxisome proliferation-associated enzymes in several rodent species. A short-term administration study.
    Sakuma M; Yamada J; Suga T
    Biochem Pharmacol; 1992 Mar; 43(6):1269-73. PubMed ID: 1532890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic microsomal enzyme induction, beta-oxidation, and cell proliferation following administration of clofibrate, gemfibrozil, or bezafibrate in the CD rat.
    Amacher DE; Beck R; Schomaker SJ; Kenny CV
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):143-50. PubMed ID: 9007043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the induction of hepatic peroxisome proliferation by the herbicide oxadiazon in vivo in rats, mice, and dogs and in vitro in rat and human hepatocytes.
    Richert L; Price S; Chesne C; Maita K; Carmichael N
    Toxicol Appl Pharmacol; 1996 Nov; 141(1):35-43. PubMed ID: 8917673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferation of peroxisomes without simultaneous induction of the peroxisomal fatty acid beta-oxidation.
    Baumgart E; Völkl A; Pill J; Fahimi HD
    FEBS Lett; 1990 May; 264(1):5-9. PubMed ID: 2338145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species differences in induction of hepatic enzymes by BM 17.0744, an activator of peroxisome proliferator-activated receptor alpha (PPARalpha).
    Meyer K; Völkl A; Endele R; Kühnle HF; Pill J
    Arch Toxicol; 1999 Nov; 73(8-9):440-50. PubMed ID: 10650915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of oral administration of bezafibrate on peroxisomes and carnitine acetyltransferase in rat hepatocytes.
    Ohue M; Makita T
    J Vet Med Sci; 1994 Jun; 56(3):541-6. PubMed ID: 7948386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of fatty acid binding protein by peroxisome proliferators in primary hepatocyte cultures and its relationship to the induction of peroxisomal beta-oxidation.
    Brandes R; Kaikaus RM; Lysenko N; Ockner RK; Bass NM
    Biochim Biophys Acta; 1990 Apr; 1034(1):53-61. PubMed ID: 2328261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative studies on nafenopin-induced hepatic peroxisome proliferation in the rat, Syrian hamster, guinea pig, and marmoset.
    Lake BG; Evans JG; Gray TJ; Körösi SA; North CJ
    Toxicol Appl Pharmacol; 1989 Jun; 99(1):148-60. PubMed ID: 2499080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunochemical identity of peroxisomal enoyl-CoA hydratase with the peroxisome-proliferation-associated 80,000 mol wt polypeptide in rat liver.
    Reddy MK; Qureshi SA; Hollenberg PF; Reddy JK
    J Cell Biol; 1981 Jun; 89(3):406-17. PubMed ID: 6788778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic zonation of the induction of cytochrome P450 IVA, peroxisomal lipid beta-oxidation enzymes and peroxisome proliferation in rats treated with dehydroepiandrosterone (DHEA). Evidence of distinct zonal and sex-specific differences.
    Beier K; Völkl A; Metzger C; Mayer D; Bannasch P; Fahimi HD
    Carcinogenesis; 1997 Aug; 18(8):1491-8. PubMed ID: 9276621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of hypolipidemic peroxisome proliferator administration on hepatic hydrogen peroxide metabolism in rats.
    Tamura H; Iida T; Watanabe T; Suga T
    Carcinogenesis; 1990 Mar; 11(3):445-50. PubMed ID: 2311188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.